MAS1L and susceptibility to pneumonia measurement: Similar to the invention of anti-HIV drug Nvevir peptide [32], the discovery of ACE2/Ang 1–7/MasR axis is recognized as a major breakthrough for the discovery of antihypertensive drugs and the treatment of viral pneumonia, including COVID-19 induced pneumonia.